SCHEMBL6465290

SCHEMBL6465290

O=C(O)NCCCCC(=O)NCC(O)(CCc1ccccc1)c1nc(C(=O)NCc2cccnc2)co1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPT P10636 1/20 0.45
HTT P42858 3/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
PTAFR P25105 1/20 0.41
TBXA2R P21731 2/20 0.41
TBXAS1 P24557 2/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 1/20 0.41
POLB P06746 1/20 0.40
TSHR P16473 1/20 0.40
FES P07332 1/20 0.40
RET P07949 1/20 0.40
MARK3 P27448 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6463781 0.92 SMN1; SMN2 (0.39) MAPTALDH1A1SMN1; SMN2LMNAMAPK1
SCHEMBL6463844 0.83 SLC6A9 (0.38) LMNATBXA2RKMT2APOLBTSHR
SCHEMBL7042125 0.78 L3MBTL1 (0.39) CYP3A4CYP1A2CYP2C9CYP2C19HTT
SCHEMBL6467254 0.75 MAPT (0.45) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL6465152 0.73 MAPT (0.39) CYP3A4CYP2C9CYP2C19MAPTHTT
SCHEMBL7042863 0.70 KCNA5 (0.37) CYP3A4MAPTALDH1A1SMN1; SMN2TSHR
SCHEMBL4067164 0.66 CYP3A4 (1.00) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL2843163 0.65 PTAFR (0.67) ALDH1A1PTAFRTBXAS1FESRET
SCHEMBL28851928 0.64 MAPT (0.83) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL2841099 0.63 EPHX2 (0.65) ALDH1A1PTAFRTBXAS1FESRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed